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Heme oxygenase is induced in nephrotoxic nephritis and hemin, a
stimulator of heme oxygenase synthesis, ameliorates disease. Heme
oxygenase (HO) catalyses degradation of heme to biliverdin, iron and
carbon monoxide (CO). Two isoforms exist, a constitutive form and an
inducible form (HO-1). Induction of HO-1 may have protective effects in
inflammation. We studied heterologous (HNTN) and accelerated
(ANTN) nephrotoxic nephritis in Lewis rats. Hemin, an inducer of HO-1,
(30 mmol/kg) was administered 18 hours before induction of nephritis and
72 hours later in ANTN. HO-1 was not detected immunohistochemically
in normal glomeruli but was present in HNTN and ANTN in cells with the
morphology of macrophages. HO-1 induction was confirmed by RT-PCR.
In normal rats hemin induced glomerular HO-1 mRNA at 18 hours. In
HNTN hemin markedly reduced proteinuria at 24 hours (10 6 4 mg/24 hr;
control 54 6 16; P , 0.05), neutrophil infiltration at two hours (29.8 6 1.8
vs. 22.3 6 1.5 neutrophils/glomerulus, P , 0.05), and glomerular macro-
phage number at two hours (2.1 6 0.1 vs. 3.1 6 0.4 cells/glomerulus, P ,
0.05). In ANTN proteinuria was reduced at day 1 and day 4 (36 6 11 vs.
60 6 15 and 35 6 7 vs. 86 6 9 mg protein/24 hr, respectively, P , 0.001),
glomerular thrombi were reduced by hemin at day 1 and 4 (1.5 6 2.7 vs.
2.7 6 0.2 and 1.3 6 0.01 vs. 2.9 6 0.02, respectively, P , 0.001) and
glomerular macrophage infiltration was reduced on day 4 (11.2 6 0.8
cells/glom; control 15.9 6 0.8, P , 0.01). Possible mechanisms by which
HO-1 ameliorates disease include anti-complement or anti-oxidant effects
of bilirubin and vasodilator and anti-platelet effects of carbon monoxide.
Heme oxygenase (HO) is the rate limiting enzyme in heme
catabolism catalyzing the oxidative cleavage of heme molecules to
biliverdin, carbon monoxide and iron (Fig. 1) [1–3]. Biliverdin is
subsequently converted to bilirubin by biliverdin reductase. There
are two isoforms of HO that are products of separate genes: HO-2
is a constitutive form which is found in tissues such as the brain
and testis; HO-1 is an inducible form of the enzyme and its
induction is important in the response of tissues to oxidative stress
and inflammation. Endotoxin, interleukin 1, heat shock and other
stress agents lead to a rapid activation of the HO-1 gene [2], and
the promoter for rat HO-1 has been shown to contain a heat shock
consensus element [4], and NF-kB [5] and AP-1 [6] binding sites
consistent with its induction by inflammatory stimuli. Heme
oxygenase-1 is also induced by its substrate hemin (ferriprotopor-
phyrin IX chloride) [1].
Heme oxygenase-1 has a number of potential protective effects
in inflammation [2]. Firstly, bilirubin has both antioxidant [7] and
anticomplement [8] effects. Secondly, carbon monoxide, in a
fashion similar to nitric oxide, may up-regulate cGMP [9] and lead
to vasodilation and inhibition of platelet aggregation. Thirdly,
degradation of heme by HO leads to the induction of ferritin
synthesis, which may then sequester iron and prevent it from
participating in subsequent oxidative injury [10]. In vitro, gene
transfection leading to increased synthesis of HO-1 has been
shown to protect pulmonary epithelial cells against oxidant stress
[11] and endothelial cells against hemoglobin toxicity [12]. In vivo,
increased HO-1 activity was shown in a model of acute inflam-
mation in the rat induced by injection of carageenin into the
peritoneal cavity [13], and inflammation was reduced by stimulat-
ing HO-1 synthesis with hemin before induction of the disease.
Heme oxygenase-1 was predominantly found in macrophages.
Glomerular mesangial cells show rapid induction of HO-1
mRNA when stimulated with phorbol myristate acetate or heat
shock [14]. Interleukin-1b (IL-1b) leads to a slower induction of
HO-1 and this effect is potentiated by the cyclooxygenase inhib-
itor indomethacin. Therefore, in view of the potential for HO-1
synthesis by both mesangial cells and macrophages, its antioxidant
effects and the importance of oxidative free radical damage in
glomerular inflammation [15], we have examined the synthesis of
HO-1 in nephrotoxic nephritis and studied the effect of adminis-
tering hemin, an inducer of HO-1 synthesis.
METHODS
Rats
Inbred male Lewis rats, from St Mary’s Hospital Medical
School, weighing between 250 and 350 g were used.
Glomerulonephritis
Accelerated nephrotoxic nephritis (ANTN) [16, 17] was in-
duced by intraperitoneal immunization of rats with 1 mg rabbit
IgG (Sigma chemicals Ltd, Poole, UK) in Freund’s complete
adjuvant (Sigma) one week prior to an intravenous, subnephrito-
genic, dose of rabbit anti-rat nephrotoxic globulin (NTG) 3 mg
IgG/100 g body wt. Heterologous nephrotoxic nephritis was
induced by a single intravenous nephritogenic dose of rabbit
anti-rat NTG (6 mg/100 g body wt IgG).
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Hemin administration
To investigate the effect of HO-1 induction on these models of
nephritis, hemin (30 mmol/kg) (ferriprotoporphyrin IX chloride;
Porphyrin products Inc., Logan, UT, USA) a heme oxygenase
inducer, or saline vehicle, was administered subcutaneously 24
hours before NTG in both models, and again at day 3 in the
accelerated model. In the accelerated model urine was collected
from rats placed in metabolic cages at days 0 to 1 and 3 to 4 after
NTG, and the proteinuria determined by the sulphosalicylic acid
method. A renal biopsy was taken at day 1, and animals killed at
day 4. In the heterologous model urine was collected as before for
24 hours; animals were killed at either two hours or 24 hours.
Hemin was also given to normal rats to study induction of HO-1
after 24 hours.
Histology and immunohistochemistry
Kidneys or renal biopsies were fixed in formal saline and
paraffin embedded. Sections were stained with hematoxylin and
eosin for neutrophil counting and thrombus detection. Thrombi
were scored as the mean number of glomerular quadrants af-
fected.
For HO-1 immunohistochemistry, sections were dewaxed, mi-
crowaved [18], blocked for one hour in 20% normal swine serum
in phosphate buffered saline (NSS/PBS) and incubated overnight
with rabbit anti-HO-1 (Stressgen Corp., Victoria, Canada) diluted
1/5000 in NSS/PBS. Endogenous peroxidase activity was blocked
with 1% H2O2 in methanol for 20 minutes, and the sections then
incubated with biotinylated swine anti-rabbit IgG (Dako Ltd.,
Bucks) at 1/1000 in NSS/PBS for 30 minutes. StreptABComplex-
HRP (Dako) was prepared following the manufacturer’s instruc-
tions and incubated for 30 minutes. 3,39-Diaminobenzidine-4HCl
was used as the chromagen. Controls consisted of either normal
rabbit serum in place of the primary antibody, or rabbit anti-rat
HO-1 that had been pre-absorbed with HO-1 (10 mg HO-1
protein/ml antibody for 1 hr at 37°C). Macrophages were detected
on microwaved sections using ED1 antibody (Serotec Ltd., Oxon,
UK) at 1:500.
Reverse transcription-polymerase chain reaction
Glomeruli were isolated by sieving as previously described [17].
In order to preserve the integrity of the glomerular RNA, kidneys
were perfused and sieved using diethyl pyrocarbonate (DEPC)
treated PBS, sieves were baked at 280°C for four hours, and
RNAse free plasticware was used at all stages.
RNA was isolated from glomeruli using RNAzol B (Biogenesis)
following the manufacturer’s instructions. RNA was quantified
and reverse transcribed using Moloney murine leukemia virus
reverse transcriptase (Gibco BRL, Paisley, UK), and the resulting
cDNA amplified by polymerase chain reaction (PCR). The HO-1
primers were as described by Paschen et al [19] and were
purchased from Oswel DNA services. The sense primer was:
59-TGGAAGAGGAGATAGAGCGA-39, and the antisense 59-
TGTTGAGCAGGAAGGCGGTC-39. The amplification product
length was 451 bp. The identity of the PCR product was confirmed
by digestion with NcoI which yielded the expected products of
lengths 280 and 171 bp. The conditions for PCR were a hot start
of 94°C five minutes, followed by cycling of one minute 60°C, one
minute 72°C and one minute 94°C for 30 cycles. The reaction was
finished with two minutes at 60°C and 10 minutes at 72°C.
Polymerase chain reaction products were analyzed on a 2%
agarose gel and visualized with ethidium bromide and ultraviolet
transillumination. In order to allow a semiquantitative estimate of
mRNA for comparison between samples, each PCR run was
carried out with three dilutions of template cDNA.
Statistics
Data are presented as mean 6 SEM. Student’s unpaired t-test
was used for comparison between groups.
RESULTS
Heme oxygenase-1 expression in control animals
Control animals (non-immunized and those immunized with
rabbit IgG in Freund’s adjuvant 7 days previously) were examined
by immunohistochemistry for the expression of HO-1. In neither
case was staining observed in the glomeruli, tubules or vessels
(Fig. 4A). Reverse transcription (RT)-PCR of glomeruli showed
no HO-1 mRNA (Fig. 2A).
Induction of heme oxygenase-1 by hemin
Hemin was given subcutaneously to normal rats to examine the
induction of HO-1 in the kidney. Reverse transcription (RT)-PCR
of the glomeruli demonstrated that HO-1 mRNA was induced 18
hours after hemin administration (Fig. 2B).
Heme oxygenase-1 expression in nephrotoxic nephritis
Heme oxygenase-1 mRNA and protein expression was exam-
ined in both accelerated and heterologous NTN. Heme oxygen-
ase-1 mRNA was detected by RT-PCR at days 1, 2, 4, 6 and 7 in
ANTN and at two hours in HNTN (Fig. 3). By immunohistochem-
istry, HO-1 positive cells were observed in the glomeruli of ANTN
rats at day 1 and day 4 (2.5 6 0.4 and 3.8 6 0.5 cells/glomerulus,
Fig. 1. Pathway of heme degradation by heme
oxygenase.
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respectively), with no significant staining of the tubules at either
time point (Fig. 4B). No vascular staining was seen. The staining
in glomerular cells appeared to be mainly in mononuclear cells,
many of which were intraluminal. These cells appeared identical
to those stained by the macrophage marker ED1.
In HNTN there was faint diffuse tubular staining after two
hours, but no detectable HO-1 in the glomeruli. After 24 hours
strong tubular staining was observed, and 0.6 6 0.2 HO-1 positive
cells were seen per glomerulus (Fig. 4C). No vascular staining was
seen. In neither model was staining seen using rabbit IgG in the
place of the anti-HO-1 antibody, and staining was completely
abolished by pre-absorption of the primary antibody with HO-1
peptide.
Effect of hemin, a heme oxygenase-1 inducer, on nephrotoxic
nephritis
Accelerated nephrotoxic nephritis. Preimmunized rats given NTG
developed a proliferative glomerulonephritis with proteinuria. At
24 hours the glomerular infiltrate was predominately macro-
phages, and macrophage infiltration persisted to day 4. Hemin
caused a significant reduction in proteinuria of 39.5% at day 0 to
1, and 59% at day 3 to 4 (36 6 11 vs. 60 6 15 and 35 6 7 vs. 86 6
9 mg protein/24 hr, P 5 0.001, respectively; Fig. 5A). Protein
excretion in normal rats was 7.7 6 1.8 mg/24 hours (N 5 8), and
in normal rats given hemin was 9.8 6 1.7 mg/24 hours (N 5 3).
Glomerular thrombosis was also significantly reduced by hemin at
days 1 and 4 (1.5 6 0.1 vs. 2.7 6 0.2. and 1.3 6 0.01 vs. 2.9 6 0.02,
respectively, P , 0.001; Fig. 5B). Animals receiving hemin showed
reduction of glomerular macrophage numbers of 30% at day 4
(11.2 6 0.8 vs. 15.9 6 0.8, P 5 0.003). No change was observed at
d1 (13.6 6 1.4 vs. 13.9 6 2.7) (Fig. 5C). Reverse transcription-
PCR using HO-1 primers demonstrated the expected 451 bp
product, with no difference between treated and untreated ani-
mals.
Heterologous nephrotoxic nephritis. Hemin administration signif-
icantly reduced proteinuria during the first 24 hours by 82% (10 6
4 vs. 54 6 16 mg protein/24 hr, P 5 0.03; Fig. 6A). At two hours,
glomerular neutrophil infitration was reduced by hemin adminis-
tration from 29.8 6 1.8 to 22.3 6 1.5 neutrophils/glomerulus (P ,
0.05; Fig. 6C). Very few neutrophils were observed at 24 hours.
Macrophage infiltration (ED-1 positive cells) was reduced by
hemin at two hours but not 24 hours (2.1 6 0.1 vs. 3.1 6 0.4, P ,
0.05, and 8.2 6 0.6 vs. 8.2 6 0.9 cells/glomerulus, respectively; Fig.
6B). Heme oxygenase-1 mRNA was detected in glomeruli at two
hours but no difference was observed between the two groups.
The strong tubular staining seen at 24 hours in HNTN was
markedly reduced in animals pretreated with hemin.
DISCUSSION
In this study we show that the inducible form of heme oxygen-
ase, HO-1, is induced in glomeruli during proliferative glomeru-
lonephritis and that administration of hemin, which augments
HO-1 synthesis, leads to amelioration of disease. Heme oxygen-
ase-1 was not detectable in normal glomeruli by RT-PCR or
immunohistochemistry but was rapidly induced in glomerulone-
phritis. By RT-PCR, HO-1 mRNA was detected by two hours in
HNTN and in ANTN was increased up to seven days. Immuno-
histochemical staining suggested that macrophages were the
major site of glomerular HO-1 synthesis. Although definite stain-
ing of intrinsic glomerular cells was not seen, glomerular mesan-
gial cells in vitro have been shown to synthesize HO-1 in response
to stimulation by phorbol esters, heat shock and IL-1b [14], and
we cannot exclude a contribution to glomerular HO-1 from these
cells. It may be that our immunohistochemical method is not
sensitive enough to detect low levels of expression by intrinsic
glomerular cells. This possibility is supported by the fact that
hemin administration to normal animals led to glomerular HO-1
mRNA synthesis at 24 hours, although we were unable to detect
HO-1 immunohistochemically. In other inflammatory models
macrophages have been shown to be a major source of HO-1. In
acute pleurisy induced by injection of carageenin into the pleural
cavities of rats [13], there was an initial influx of neutrophils
followed by increasing numbers of macrophages. Heme oxygenase
activity increased as the inflammation progressed and by 48 hours
89% of infiltrating macrophages stained positively for HO-1. The
HO-1 activity in macrophages from the pleural cavity was eight
times that in peripheral blood monocytes. In a model of renal
transplant rejection in the rat, marked induction of HO-1 was
found at day 5 and immunohistochemistry showed that the major
source was infiltrating macrophages [20]. There are many possible
mediators that may induce HO-1 in monocytes that infiltrate the
glomeruli in glomerulonephritis including reactive oxygen species
[21], IL-1 and tumor necrosis factor [22], and nitric oxide [23, 24].
Fig. 2. Reverse transcription-polymerase chain reaction (RT-PCR) for
heme oxygenase-1 (HO-1) in rat glomeruli from (A) control animals and
(B) normal animals 24 hours after hemin administration. In each case 1,
0.1 or 0.01 mg of cDNA were used for PCR.
Fig. 3. Reverse transcription-polymerase chain reaction (RT-PCR) for
heme oxygenase-1 (HO-1) in rat glomeruli from a representative animal
with (A) accelerated nephrotoxic nephritis (ANTN) at one day, and (B)
heterologous nephrotoxic nephritis (HNTN) at two hours. The numbers
beneath the lanes show mg of cDNA used for PCR.
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In addition, phagocytosis induces HO-1 in mononuclear phago-
cytes [25]. All of these stimuli are potential inducing agents in the
inflamed glomerulus.
This is the first demonstration of the induction of HO-1 in
glomeruli, although induction has been shown in the renal tubules
of rats with HNTN [26]. Heme oxygenase-1 was demonstrated
immunohistochemically in tubular cells at 6 and 24 hours after
injection of nephrotoxic globulin, and our results confirm that
there is HO-1 staining in tubules at 24 hours in HNTN. However,
in this previous study, no HO-1 staining was seen in glomeruli.
The reason for this diffence is not clear, but comparison with our
model is difficult since there was no description of glomerular
histology or of levels of proteinuria. The induction of tubular
HO-1 was associated with resistance to glycerol-induced acute
renal failure as judged by serum creatinine and histological
damage.
There is evidence that HO-1 is protective against oxidative
injury, and therefore we hypothesized that its induction in the
glomerulus would have an anti-inflammatory effect. To test this
we examined the effect of stimulating its synthesis prior to
Fig. 4. Immunohistochemistry for heme oxygenase-1 (HO-1) (immuno-
peroxidase with hematoxylin counterstain). (A) Normal animal. No
staining for HO-1 is seen. (B) Accelerated nephrotoxic nephritis (ANTN)
at four days. Many positive cells are seen in the glomerulus. (C)
Heterologous nephrotoxic nephritis (HNTN) at one day. Many tubules
are stained.
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induction of glomerulonephritis by administering the natural
substrate hemin, which is a well characterized and potent inducer
of HO-1. It has been previously shown that hemin administration
reduces inflammation in carageenin-induced pleurisy in the rat as
measured by inflammatory cell infiltration and exudate volume
[13]. In normal rats hemin led to induction of glomerular mRNA
for HO-1 24 hours later, without any effect on glomerular
histology or urinary protein excretion. In HNTN, prior adminis-
tration of hemin almost abolished the proteinuria in the first 24
hours, and led to a small but significant reduction in neutrophil
and macrophage numbers at two hours. In ANTN hemin also
reduced proteinuria, glomerular thrombus formation at 24 hours
and macrophage infiltration at four days. However, we recognize
that hemin may have other actions and that we are not able to be
certain that its benefical effect is through induction of HO-1.
There are several possible reasons why HO-1 induction might
have beneficial effects and they may operate together. The
proteinuria and neutrophil infiltration in HNTN are dependent
on the activation of complement by bound antibody. Biliverdin is
an inhibitor of the complement cascade at the level of C1
activation in the classical pathway [27]. The slight reduction we
found in infiltrating neutrophils at two hours in HNTN is consis-
tent with a reduction in the generation of chemotactic factors of
complement. Reactive oxygen metabolites have been postulated
as a major mediators of neutrophil-dependent damage to the
glomerular filtration barrier [28, 29]. Induction of HO-1 by hemin
in vitro has been shown to protect renal epithelial cells against the
cytotoxic effect of H2O2. There are at least two ways in which
HO-1 may protect against damaging effects of reactive oxygen
metabolites. Firstly, bilirubin is a potent antioxidant scavenging
peroxyl radicals [7] and preventing lipid peroxidation [30] and
albumin oxidation [31]. Secondly, synthesis of ferritin, the major
iron storage protein is often induced in tandem with heme
oxygenase, most probably in response to the free iron [32, 33].
Ferritin is able to sequester large amounts of free iron and may
therefore prevent the synthesis of the damaging hydroxyl radical
from superoxide and hydrogen peroxide, a reaction which is
catalysed by iron [34]. Balla et al [35] showed that endothelial cells
respond to heme with induction of HO and ferritin and become
insensitive to oxidant damage, an effect that can also be achieved
by addition of apoferritin. The relevance of this mechanism to
glomerular inflammation is shown by a study in which chelation of
iron by administration of desferrioxamine prevented the develop-
ment of proteinuria in a complement and neutrophil dependent
model of heterologous NTN in rabbits [36].
Proteinuria in NTN may depend not only on damage to the
capillary wall but also on hemodynamic factors, and in particular
the intracapillary pressure that may be affected by afferent and
Fig. 5. Effect of hemin (f) or vehicle (M) on accelerated nephrotoxic
nephritis (ANTN) at days 1 (hemin, N 5 6; vehicle, N 5 5) and 4 (hemin,
N 5 6; vehicle, N 5 5). (A) Proteinuria; (B) thrombi; (C) macrophage
numbers. *P # 0.05, **P # 0.001.
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efferent arteriolar constriction. Elevation of transcapillary hy-
draulic pressure exacerbates proteinuria in glomerular injury [37,
38]. Carbon monoxide, a product of heme oxygenase, increases
smooth muscle cell cGMP and may therefore act to produce
vasodilation, reduced intracapillary pressure and reduced protein-
uria. The activation of platelet cGMP inhibits platelet aggregation
and platelet adhesion to collagen, and therefore carbon monoxide
may be expected to have an antithrombotic effect analogous to
that of nitric oxide [39]. This may explain the reduction in
glomerular thrombosis that we found in the accelerated model of
NTN.
We found increased staining for HO-1 at 24 hours in the
tubules of rats with HNTN as described previously [26]. In rats
treated with hemin this staining was reduced and the most
plausible explanation for this is that the induction of HO-1 in the
tubules is a secondary response to glomerular inflammation.
Possible inducers are pro-inflammatory cytokines such as tumor
necrosis factor (TNF) produced in the glomerulus and taken up by
the tubules from the urinary space, or the leakage of other plasma
proteins such as ferritin into the urine [26]. Whatever the expla-
nation, our study shows that amelioration of the glomerulonephri-
tis and proteinuria by hemin reduces the tubular induction of
HO-1.
In conclusion, this is the first demonstration that the inducible
form of heme oxygenase, a protein implicated in the protection of
tissues against oxidative stress, is up-regulated in glomeruli during
glomerular inflammation. A major source of the increased HO-1
appears to be infitrating macrophages. Administration of hemin
leads to a reduction in glomerular inflammation as assessed by
proteinuria, cellular infiltration and, in the more severe active
form of NTN, a reduction in glomerular thrombosis and we
hypothesise that this effect of hemin is via HO-1 synthesis. The
mechanism of the protective effects of HO-1 induction may
include anti-oxidant and anti-complement effects of bilirubin,
stimulation of ferritin synthesis by iron and antithrombotic and
vasodilatory effects of carbon monoxide.
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Fig. 6. Effect of hemin (f) or vehicle (M) on heterologous nephrotoxic
nephritis (HNTN) at 2 (hemin and vehicle, N 5 4) and 24 hours (hemin
and vehicle, N 5 7). (A) Proteinuria; (B) macrophage numbers; (C)
neutrophil numbers. *P , 0.05.
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